









Markets
/
Stocks
/
nasdaq-stxs
/

Stereotaxis Inc

STXS

2.030USD

+0.050+2.53%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

184.90MMarket Cap

LossP/E TTM



Stereotaxis Inc

2.030

+0.050+2.53%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Stereotaxis Inc

Currency: USD Updated: 2026-02-06

Key Insights

Stereotaxis Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 107 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.20.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stereotaxis Inc's Score

Industry at a Glance

Industry Ranking

107 / 205

Overall Ranking

284 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Stereotaxis Inc Highlights

StrengthsRisks

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Growing

The company is in a growing phase, with the latest annual income totaling USD 26.92M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 26.92M.

Fairly Valued

The company’s latest PE is -7.20, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 43.86M shares, decreasing 4.20% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 5.27K shares of this stock.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

4.200

Target Price

+112.12%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Stereotaxis Inc is 6.19, ranking 166 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 7.46M, representing a year-over-year decrease of 18.83%, while its net profit experienced a year-over-year decrease of 4.10%.

Score

Industry at a Glance

Previous score

6.19

Change



Financials

6.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.10

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

5.17

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.61

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Stereotaxis Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Stereotaxis Inc is 6.86, ranking 142 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -7.20, which is -28.24% below the recent high of -5.17 and -74.68% above the recent low of -12.58.

Score

Industry at a Glance

Previous score

6.86

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 107/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Stereotaxis Inc is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 4.00, with a high of 5.00 and a low of 4.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

4.200

Target Price

+112.12%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Stereotaxis Inc

STXS

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Stereotaxis Inc is 6.57, ranking 126 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.60 and the support level at 1.72, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.47

Change

0.1

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.140

Sell

RSI(14)

30.557

Neutral

STOCH(KDJ)(9,3,3)

5.356

Oversold

ATR(14)

0.124

High Vlolatility

CCI(14)

-106.743

Sell

Williams %R

94.048

Oversold

TRIX(12,20)

-0.487

Sell

StochRSI(14)

49.622

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

2.098

Sell

MA10

2.262

Sell

MA20

2.469

Sell

MA50

2.423

Sell

MA100

2.641

Sell

MA200

2.489

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Stereotaxis Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 46.99%, representing a quarter-over-quarter increase of 2.67%. The largest institutional shareholder is The Vanguard, holding a total of 3.69M shares, representing 3.96% of shares outstanding, with 3.74% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Fischel (Nathan)

13.92M

+0.31%

Dafna Capital Management, LLC

13.68M

Kiani (Joe E)

8.86M

+5.07%

Lagoda Investment Management, L.P.

4.71M

+0.42%

The Vanguard Group, Inc.

Star Investors

3.44M

+4.19%

BlackRock Institutional Trust Company, N.A.

3.68M

+2.13%

2012 Revocable Trust of Andrew Redleaf

3.08M

Arbiter Partners Capital Management, LLC

2.85M

Isaac (Paul J)

2.06M

+0.49%

Essex Investment Management Company, LLC

1.60M

+3.45%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Stereotaxis Inc is 2.88, ranking 140 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.39. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.